DOCSLIB.ORG

TRPV Channels and Their Pharmacological Modulation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
TRPV Channels and Their Pharmacological Modulation Cellular Physiology Cell Physiol Biochem 2021;55(S3):108-130 DOI: 10.33594/00000035810.33594/000000358 © 2021 The Author(s).© 2021 Published The Author(s) by and Biochemistry Published online: online: 28 28 May May 2021 2021 Cell Physiol BiochemPublished Press GmbH&Co. by Cell Physiol KG Biochem 108 Press GmbH&Co. KG, Duesseldorf SeebohmAccepted: 17et al.:May Molecular 2021 Pharmacology of TRPV Channelswww.cellphysiolbiochem.com This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Review Beyond Hot and Spicy: TRPV Channels and their Pharmacological Modulation Guiscard Seebohma Julian A. Schreibera,b aInstitute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany, bInstitut für Pharmazeutische und Medizinische Chemie, Westfälische Wilhelms-Universität Münster, Münster, Germany Key Words TRPV • Molecular pharmacology • Capsaicin • Ion channel modulation • Medicinal chemistry Abstract Transient receptor potential vanilloid (TRPV) channels are part of the TRP channel superfamily and named after the first identified member TRPV1, that is sensitive to the vanillylamide capsaicin. Their overall structure is similar to the structure of voltage gated potassium channels (Kv) built up as homotetramers from subunits with six transmembrane helices (S1-S6). Six TRPV channel subtypes (TRPV1-6) are known, that can be subdivided into the thermoTRPV 2+ (TRPV1-4) and the Ca -selective TRPV channels (TRPV5, TRPV6). Contrary to Kv channels, TRPV channels are not primary voltage gated. All six channels have distinct properties and react to several endogenous ligands as well as different gating stimuli such as heat, pH, mechanical stress, or osmotic changes. Their physiological functions are highly diverse and subtype as well as tissue specific. In many tissues they serve as sensors for different pain stimuli (heat, pressure, pH) and contribute to the homeostasis of electrolytes, the maintenance of barrier functions and the development of macrophages. Due to their fundamental role in manifold physiological and pathophysiological processes, TRPV channels are promising targets for drug development. However, drugs targeting specific TRPV channels, that are suitable for drug therapy, are rare. Moreover, selective and potent compounds for further research at TRPV channels are often lacking. In this review different aspects of the structure, the different gating stimuli, the expression pattern, the physiological and pathophysiological roles as well as the modulating mechanisms of synthetic, natural and endogenous ligands are summarized. © 2021 The Author(s). Published by Cell Physiol Biochem Press GmbH&Co. KG The structure of TRPV channels In 1969 Cosens and Manning described a mutated Drosophila melanogaster strain, that showed abnormal electroretinogram (ERG) and impaired phototransduction. The ERG was characterized by a transient receptor potential (TRP) instead of a rather sustained potential in the wildtype [1]. Later, this mutated strain was associated with the first invertebrate TRP Dr. Julian Alexander Schreiber IfGH – Cellular Electrophysiology and Molecular Biology, Department of Cardiovascular Medicine, University Hospital Muenster Robert-Koch-Straße 45, Muenster, D-48149 (Germany) Tel. +49-251-83-58278, E-Mail [email protected] Cellular Physiology Cell Physiol Biochem 2021;55(S3):108-130 DOI: 10.33594/000000358 © 2021 The Author(s). Published by and Biochemistry Published online: 28 May 2021 Cell Physiol Biochem Press GmbH&Co. KG 109 Seebohm et al.: Molecular Pharmacology of TRPV Channels cation channel, which was cloned A B in 1989 [2]. Finally, in 1995 the C5 C3 C1C4 C7 C6 M5 the transient receptor potential M4 V1 M8 V2 canonicalfirst mammalian (TRPC) homologue family, was of M2 V4 cloned and characterized [3, 4]. M7 V3 M6 V5 From then to now 28 members M3M1 V6 of the TRP cation channel A1 P3 ML1 P5 P2 ML3 ML2 superfamily were discovered in by sequence homology into C D twomammals, groups that andcan be6 subdivided families: Group I contains the families transient potential receptor S1 S2 S3 S4 S5 S6 (TRPV1-6), ankyrin (TRPA1) and Linker TRP Helix melastatincanonical (TRPC1-7),(TRPM1-8), vanilloid while N-Linker the families polycystin (TRPP2, COOH TRPP3, TRPP5) and mucolipin (TRPML1-3) belong to Group II NH (Fig. 1A) [5, 6]. The TRPV 2 channels are named after the Fig. 1. A. Phylogenetic tree of TRP channels found in human in- first discovered member TRPV1, ankyrin (A1), melastatin (M1-8), polycystin (P2, P3, P5) and cluding the subfamilies canonical (C1, C3-C7), vanilloid (V1-6), TRPV1that is sensitive is formed to bystimulation assembling by ofthe fourvanillylamide TRPV1 subunits,capsaicin that[7]. 5IRX) embedded into cell membrane [129]. Single subunits are coloredmucolipin in (ML1-3).magenta, B.green, Homotetrameric blue, and yellow. TRPV1 C andchannel D. Schematic (PDB ID + channelshave a similar (Fig. 1B-D) transmembrane [8, 9]. Later 5IRX) of a single TRPV1 subunit including the N-terminal domain depiction (C) and corresponding Cryo-EM structure (D; PDB ID structure like voltage gated K (NTD, orange), the ankyrin repeat domain (ARD, orange), the N- terminal linker (N-linker, orange), the pre-S1 helix (Pre-S1, or- VRL1),on, the vanilloidTRPV3 (OLMS,subfamily VRL3), was TRPV4extended (VRL2, by TRPV2 Trp12, (previously VROAC, linker (Linker, red), the inner pore domain (S5-S6, magenta), the ange), the voltage-sensing-like domain (S1-S4; purple), the S4S5- OTRPC4), TRPV5 (ECaC1, CaT2) - and TRPV6 (ECaC2, CaT1) [10– nal domain (CTD, yellow) [129]. pore helix (PH, magenta), the TRP helix (green) and the C-termi 13]. All TRPV channels possess a large cytosolic N-terminal and a smaller C-terminal region [14]. The N-terminal region forms an ankyrin repeat domain (ARD) with six ankyrin repeats, two β-sheets (N-Linker) and a pre-S1 helix (Fig. 1C) [15]. The cytosolic C-terminal region intracellularencompasses regions several areamino also acids binding forming sites one for β-sheet,modulating that proteins together and with second the two messengers. N-terminal Theβ-sheets N-terminus and the contains ARD of an binding adjacent sites subunit for calmodulin allow for (CaM) efficient and subunit ATP, that assembling both can modulate[15]. The stronglychannel activityregulated [16]. by Thephosphorylation shorter C-terminal at different region sites also of binds the N-CaM and and C-terminal other regulating regions proteins including A-kinase anchor protein (AKAP) [17, 18]. Moreover, TRPV channels are likeperformed domain by (VSLD, protein S1-S4) kinase and A (PKA)an inner as wellpore as region protein (S5-S6) kinase connected C (PKC) [19, by 20].the S4S5-linker The transmembrane region consists of six helices (S1-S6) forming the voltage sensor- also called pore turret) between the S5 and S6 helix [22]. Further, residues from the lower [21]. The ion channel pore is formed by the selectivity filter (SF) and the pore helix (PH; part of the S6 helix form an activation gate [23]. In comparison to voltage gated potassium channels, the upper gate formed by the PH / SF is shorter and the pore radius differs within Cellular Physiology Cell Physiol Biochem 2021;55(S3):108-130 DOI: 10.33594/000000358 © 2021 The Author(s). Published by and Biochemistry Published online: 28 May 2021 Cell Physiol Biochem Press GmbH&Co. KG 110 Seebohm et al.: Molecular Pharmacology of TRPV Channels the different TRPV subtypes influencing the selectivity of the channels [24]. Based on the Caion2+ selectivity the six subtypes are2+ subdivided+ ranging into two from groups: P TRPV1-4 form polyselective upcation to 10channels, (TRPV1, that TRPV3) conduct [25]. monovalent In contrast, as wellTRPV5 as divalentand TRPV6 cations are withnearly a preferenceCa2+ for Ca/Na channelsand conductivity with P ratios for Ca over Na 3 (TRPV2) over 6 (TRPV4) cations [26, 27]. selective Ca/Na >100, while monovalent cations only permeate in absence of divalent Gating stimuli of TRPV channels Although the structure of the transmembrane region is similar to the structure of voltage gated potassium channels, the voltage dependency of TRPV channels is rather low [28]. Together with another activation stimulus (agonist, pH or heat), TRPV1 as well as TRPV4 show a prominent outward rectification at highly positive voltages and slight inward rectification at negative voltages [28, 29]. Only TRPV1 exerts weak voltage dependent opening without any other stimulus [28]. TRPV3 does not show voltage dependent activation up to highly positive voltages without additional stimulation by heat or ligands [30]. However, activation of TRPV3 by 2-APB leads to similar voltage dependency as observed for TRPV1 [31]. TRPV2 channels exert also dual rectification with slightly dominant outward currents2+ under heat activationpotentials [10].[32, 33].In contrast The ion tochannels the polyselective of the two TRPVTRPV channelsgroups differ TRPV5 additionally and TRPV6 in showheat- strong inward rectification due to voltage-dependent intracellular Mg -block at positive 10 nosensitive altered gating. gating at different temperatures [34]. Thus, TRPV1-4 are also called thermoTRPV channelsWhile contributing TRPV1-4 are to sensitive temperature to heat sensing showing in Qvivo values [24]. >10,While TRPV5 TRPV4 and (threshold TRPV6 show 24- of33
Load more

Recommended publications
  • 1 TRP About Online
    a TR P to Spain International Workshop on Transient Receptor Potential Channels 12th – 14th September 2012 Valencia, Spain www.trp2012.com SCHEDULE and ABSTRACTS BOOK September 2012 Dear participants, Travelling to faraway places in search of spiritual or cultural enlightenment is a millennium old human activity. In their travels, pilgrims brought with them news, foods, music and traditions from distant lands. This friendly exchange led to the cultural enrichment of visitors and the economic flourishing of places, now iconic, such as Rome, Santiago, Jerusalem, Mecca, Varanasi or Angkor Thom. The dissemination of science and technology also benefited greatly from these travels to remote locations. The new pilgrims of the Transient Receptor Potential (TRP) community are also very fond of travelling. In the past years they have gathered at various locations around the globe: Breckenridge (USA), Eilat (Israel), Stockholm (Sweden) and Leuven (Belgium) come to mind. These meetings, each different and exciting, have been very important for the dissemination of TRP research. We are happy to welcome you in Valencia (Spain) for TRP2012. The response to our call has been extraordinary, surpassing all our expectations. The speakers, the modern bards, readily attended our request to communicate their new results. At last count we were already more than 170 participants, many of them students, and most presenting their recent work in the form of posters or short oral presentations. At least 25 countries are sending TRP ambassadors to Valencia, making this a truly international meeting. We like to thank the staff of the Cátedra Santiago Grisolía, Fundación Ciudad de las Artes y las Ciencias for their dedication and excellence in handling the administrative details of the workshop.
    [Show full text]
  • Therapeutic Targets for the Treatment of Chronic Cough
    Therapeutic Targets for the Treatment of Chronic Cough Roe, N., Lundy, F., Litherland, G. J., & McGarvey, L. (2019). Therapeutic Targets for the Treatment of Chronic Cough. Current Otorhinolaryngology Reports. https://doi.org/10.1007/s40136-019-00239-9 Published in: Current Otorhinolaryngology Reports Document Version: Publisher's PDF, also known as Version of record Queen's University Belfast - Research Portal: Link to publication record in Queen's University Belfast Research Portal Publisher rights Copyright 2019 the authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. General rights Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the Research Portal that you believe breaches copyright or violates any law, please contact [email protected]. Download date:25. Sep. 2021 Current Otorhinolaryngology Reports https://doi.org/10.1007/s40136-019-00239-9 CHRONIC COUGH (K ALTMAN, SECTION EDITOR) Therapeutic Targets for the Treatment of Chronic Cough N.
    [Show full text]
  • TRP Mediation
    molecules Review Remedia Sternutatoria over the Centuries: TRP Mediation Lujain Aloum 1 , Eman Alefishat 1,2,3 , Janah Shaya 4 and Georg A. Petroianu 1,* 1 Department of Pharmacology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] (L.A.); Eman.alefi[email protected] (E.A.) 2 Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates 3 Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman 11941, Jordan 4 Pre-Medicine Bridge Program, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] * Correspondence: [email protected]; Tel.: +971-50-413-4525 Abstract: Sneezing (sternutatio) is a poorly understood polysynaptic physiologic reflex phenomenon. Sneezing has exerted a strange fascination on humans throughout history, and induced sneezing was widely used by physicians for therapeutic purposes, on the assumption that sneezing eliminates noxious factors from the body, mainly from the head. The present contribution examines the various mixtures used for inducing sneezes (remedia sternutatoria) over the centuries. The majority of the constituents of the sneeze-inducing remedies are modulators of transient receptor potential (TRP) channels. The TRP channel superfamily consists of large heterogeneous groups of channels that play numerous physiological roles such as thermosensation, chemosensation, osmosensation and mechanosensation. Sneezing is associated with the activation of the wasabi receptor, (TRPA1), typical ligand is allyl isothiocyanate and the hot chili pepper receptor, (TRPV1), typical agonist is capsaicin, in the vagal sensory nerve terminals, activated by noxious stimulants.
    [Show full text]
  • The Mammalian TRPC Cation Channels
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1742 (2004) 21–36 http://www.elsevier.com/locate/bba Review The mammalian TRPC cation channels Guillermo Vazquez, Barbara J. Wedel, Omar Aziz, Mohamed Trebak, James W. Putney Jr.* The Calcium Regulation Section, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, 111 TW Alexander Dr., Research Triangle Park, NC 27709, United States Received 3 August 2004; received in revised form 27 August 2004; accepted 28 August 2004 Available online 11 September 2004 Abstract Transient Receptor Potential-Canonical (TRPC) channels are mammalian homologs of Transient Receptor Potential (TRP), a Ca2+- permeable channel involved in the phospholipase C-regulated photoreceptor activation mechanism in Drosophila. The seven mammalian TRPCs constitute a family of channels which have been proposed to function as store-operated as well as second messenger-operated channels in a variety of cell types. TRPC channels, together with other more distantly related channel families, make up the larger TRP channel superfamily. This review summarizes recent findings on the structure, regulation and function of the apparently ubiquitous TRPC cation channels. Published by Elsevier B.V. Keywords: Ion channel; Calcium channel; Non-selective cation channel; TRP channel; TRPC channel; Capacitative calcium entry; Store-operated channel; Second messenger-operated channel; Inositol trisphosphate receptor; Diacylglycerol; Phospholipase C 1. Origin, classification and nomenclature of TRPCs member, the vanilloid receptor; and the TRPM family, with eight members (TRPM1–8), named after the original The recognition that the protein product derived from member, melastatin (Fig.
    [Show full text]
  • Therapeutic Targets for the Treatment of Chronic Cough
    Current Otorhinolaryngology Reports https://doi.org/10.1007/s40136-019-00239-9 CHRONIC COUGH (K ALTMAN, SECTION EDITOR) Therapeutic Targets for the Treatment of Chronic Cough N. A. Roe1 & F. T. Lundy1 & G. J. Litherland2 & L. P. A. McGarvey1 # The Author(s) 2019 Abstract Purpose of Review Chronic cough, defined in adults as one lasting longer than 8 weeks, is among the commonest clinical problems encountered by doctors both in general practice and in hospital. It can exist as a distinct clinical problem or as a prominent and troublesome symptom for patients with common pulmonary conditions including asthma, chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Recent Findings Chronic cough impacts considerably on patients’ daily-life activities and many patients are left frustrated by what they see as a complete lack of awareness among their doctors as how to treat their condition. Some of this arises from limited levels of physician knowledge about managing cough as a clinical problem but also because there are no very effective treatments that specifically target cough. Summary In this article, we review the current clinical thinking regarding cough and the treatments that are currently used and those undergoing clinical development. Keywords Cough . Cough receptor . Pharmacological targets . Novel . Ion channel Introduction and is likely due to a slowly resolving post-viral cough. In adult patients, a cough persisting for more than 8 weeks is Under normal physiological circumstances, coughing occurs termed ‘chronic’ and can occur as an isolated clinical problem with the primary purpose of protecting the lung from inhaled or associated with common respiratory and non-respiratory irritants and clearing unwanted airway secretions.
    [Show full text]
  • Trpc, Trpv and Vascular Disease | Encyclopedia
    TRPC, TRPV and Vascular Disease Subjects: Biochemistry Submitted by: Tarik Smani Hajami Definition Ion channels play an important role in vascular function and pathology. In this review we gave an overview of recent findings and discussed the role of TRPC and TRPV channels as major regulators of cellular remodeling and consequent vascular disorders. Here, we focused on their implication in 4 relevant vascular diseases: systemic and pulmonary artery hypertension, atherosclerosis and restenosis. Transient receptor potentials (TRPs) are non-selective cation channels that are widely expressed in vascular beds. They contribute to the Ca2+ influx evoked by a wide spectrum of chemical and physical stimuli, both in endothelial and vascular smooth muscle cells. Within the superfamily of TRP channels, different isoforms of TRPC (canonical) and TRPV (vanilloid) have emerged as important regulators of vascular tone and blood flow pressure. Additionally, several lines of evidence derived from animal models, and even from human subjects, highlighted the role of TRPC and TRPV in vascular remodeling and disease. Dysregulation in the function and/or expression of TRPC and TRPV isoforms likely regulates vascular smooth muscle cells switching from a contractile to a synthetic phenotype. This process contributes to the development and progression of vascular disorders, such as systemic and pulmonary arterial hypertension, atherosclerosis and restenosis. 1. Introduction Blood vessels are composed essentially of two interacting cell types: endothelial cells (ECs) from the tunica intima lining of the vessel wall and vascular smooth muscle cells (VSMCs) from tunica media of the vascular tube. Blood vessels are a complex network, and they differ according to the tissue to which they belong, having diverse cell expressions, structures and functions [1][2][3].
    [Show full text]
  • Molecular Basis for Heat Desensitization of TRPV1 Ion Channels
    ARTICLE https://doi.org/10.1038/s41467-019-09965-6 OPEN Molecular basis for heat desensitization of TRPV1 ion channels Lei Luo1,2,5, Yunfei Wang1,2,5, Bowen Li1,5, Lizhen Xu3, Peter Muiruri Kamau1,2, Jie Zheng 4, Fan Yang3, Shilong Yang1 & Ren Lai1 The transient receptor potential vanilloid 1 (TRPV1) ion channel is a prototypical molecular sensor for noxious heat in mammals. Its role in sustained heat response remains poorly 1234567890():,; understood, because rapid heat-induced desensitization (Dh) follows tightly heat-induced activation (Ah). To understand the physiological role and structural basis of Dh, we carried out a comparative study of TRPV1 channels in mouse (mV1) and those in platypus (pV1), which naturally lacks Dh. Here we show that a temperature-sensitive interaction between the N- and C-terminal domains of mV1 but not pV1 drives a conformational rearrangement in the pore leading to Dh. We further show that knock-in mice expressing pV1 sensed heat normally but suffered scald damages in a hot environment. Our findings suggest that Dh evolved late during evolution as a protective mechanism and a delicate balance between Ah and Dh is crucial for mammals to sense and respond to noxious heat. 1 Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan 650223, China. 2 University of Chinese Academy of Sciences, Beijing 100049, China. 3 Key Laboratory of Medical Neurobiology, Department of Biophysics and Kidney Disease Center, First Affiliated Hospital, Institute of Neuroscience, National Health Commission and Chinese Academy of Medical Sciences, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China.
    [Show full text]
  • TRPM8 Channels and Dry Eye
    UC Berkeley UC Berkeley Previously Published Works Title TRPM8 Channels and Dry Eye. Permalink https://escholarship.org/uc/item/2gz2d8s3 Journal Pharmaceuticals (Basel, Switzerland), 11(4) ISSN 1424-8247 Authors Yang, Jee Myung Wei, Edward T Kim, Seong Jin et al. Publication Date 2018-11-15 DOI 10.3390/ph11040125 Peer reviewed eScholarship.org Powered by the California Digital Library University of California pharmaceuticals Review TRPM8 Channels and Dry Eye Jee Myung Yang 1,2 , Edward T. Wei 3, Seong Jin Kim 4 and Kyung Chul Yoon 1,* 1 Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju 61469, Korea; [email protected] 2 Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea 3 School of Public Health, University of California, Berkeley, CA 94720, USA; [email protected] 4 Department of Dermatology, Chonnam National University Medical School and Hospital, Gwangju 61469, Korea; [email protected] * Correspondence: [email protected] Received: 17 September 2018; Accepted: 12 November 2018; Published: 15 November 2018 Abstract: Transient receptor potential (TRP) channels transduce signals of chemical irritation and temperature change from the ocular surface to the brain. Dry eye disease (DED) is a multifactorial disorder wherein the eyes react to trivial stimuli with abnormal sensations, such as dryness, blurring, presence of foreign body, discomfort, irritation, and pain. There is increasing evidence of TRP channel dysfunction (i.e., TRPV1 and TRPM8) in DED pathophysiology. Here, we review some of this literature and discuss one strategy on how to manage DED using a TRPM8 agonist.
    [Show full text]
  • 102 the Effects of Intravesical
    102 Harper M, Brady C. M, Scaravilli F, Fowler C. J. Institute of Neurology, London THE EFFECTS OF INTRAVESICAL RESINIFERATOXIN ON SUBUROTHELIAL NERVE DENSITY IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY Aims of Study Somatic and autonomic neural pathways integrated in the CNS regulate urine storage and voiding. When spinal cord lesions disrupt these pathways, an aberrant segmental sacral reflex emerges, the afferent limb of which is comprised of small unmyelinated C-fibres that originate in the suburothelium. This pathological reflex is thought to be the underlying cause of “spinal” neurogenic detrusor overactivity (NDO). We are currently evaluating the role of resiniferatoxin (RTX) in the treatment of refractory “spinal” NDO. RTX is an ultra-potent capsaicin analogue purified from the dried latex of the succulent plant Euphorbia Resinifera. The vanillyl group of RTX facilitates the action of the vanilloid receptor (VR-1), a non-selective cation channel expressed on suburothelial C-fibres. Intravesical therapy with a single dose of RTX results in early acute excitatory effects (“sensitisation”) followed by inhibition of neuropeptide release and neuronal terminal field degeneration (“desensitisation”) (Avelino et al., 2001). In patients with refractory NDO, it has been shown that intravesical therapy with vanilloid compounds such as RTX or capsaicin significantly decreases lower urinary tract symptoms for a period of weeks or months, depending on factors such as dose and disease progression. It is thought that the eventual recurrence of symptoms is related to C-fibre regeneration. We have previously shown that the mean suburothelial nerve density decreases in patients who respond to capsaicin. Our experimental aim is to measure suburothelial nerve density in flexible cystoscopic biopsies in controls and patients with NDO before and after intravesical RTX or placebo.
    [Show full text]
  • Expression of Transient Receptor Potential Channels in the Ependymal Cells of the Developing Rat Brain
    Original Article http://dx.doi.org/10.5115/acb.2013.46.1.68 pISSN 2093-3665 eISSN 2093-3673 Expression of transient receptor potential channels in the ependymal cells of the developing rat brain Kwang Deog Jo1, Kyu-Seok Lee2, Won Taek Lee3, Mi-Sun Hur2, Ho-Jeong Kim2 1Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, 2Department of Anatomy, Kwandong University College of Medicine, Gangneung, 3Department of Anatomy, Yonsei University College of Medicine, Seoul, Korea Abstract: Cerebrospinal fluid (CSF) plays an important role in providing brain tissue with a stable internal environment as well as in absorbing mechanical and thermal stresses. From its initial composition, derived from the amniotic fluid trapped by the closure of neuropores, CSF is modified by developing and differentiating ependymal cells lining the ventricular surface or forming the choroid plexus. Its osmolarity and ionic composition brings about a change through the action of many channels expressed on the ependymal cells. Some newly discovered transient receptor potential (TRP) channels are known to be expressed in the choroid plexus ependyma. To detect additional TRP channel expression, immunohistochemical screening was performed at the choroid plexus of 13-, 15-, 17-, and 19-day embryos, using antibodies against TRPV1, TRPV3, and TRPA1, and the expression was compared with those in the adult TRP channels. The level of TRP channel expression was higher in the choroid plexus which suggests more active functioning of TRP channels in the developing choroid plexus than the ventricular lining ependyma in the 15- and 17-day embryos. All the expression of TRP channels decreased at the 19th day of gestation.
    [Show full text]
  • Investigational Drugs in Early Phase Clinical Trials Targeting Thermotransient Receptor Potential (Thermotrp) Channels
    Expert Opinion on Investigational Drugs ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/ieid20 Investigational drugs in early phase clinical trials targeting thermotransient receptor potential (thermoTRP) channels Asia Fernández-Carvajal , Rosario González-Muñiz , Gregorio Fernández- Ballester & Antonio Ferrer-Montiel To cite this article: Asia Fernández-Carvajal , Rosario González-Muñiz , Gregorio Fernández- Ballester & Antonio Ferrer-Montiel (2020): Investigational drugs in early phase clinical trials targeting thermotransient receptor potential (thermoTRP) channels, Expert Opinion on Investigational Drugs, DOI: 10.1080/13543784.2020.1825680 To link to this article: https://doi.org/10.1080/13543784.2020.1825680 Published online: 29 Sep 2020. Submit your article to this journal Article views: 31 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ieid20 EXPERT OPINION ON INVESTIGATIONAL DRUGS https://doi.org/10.1080/13543784.2020.1825680 REVIEW Investigational drugs in early phase clinical trials targeting thermotransient receptor potential (thermoTRP) channels Asia Fernández-Carvajala, Rosario González-Muñizb, Gregorio Fernández-Ballestera and Antonio Ferrer-Montiela aInstituto De Investigación, Desarrollo E Innovación En Biotecnología Sanitaria De Elche (Idibe), Universitas Miguel Hernández, Alicante, Spain; bInstituto De Química Médica, CSIC, Madrid, Spain ABSTRACT ARTICLE HISTORY Introduction: Thermo transient receptor potential (thermoTRP) channels are some of the most inten­ Received 15 June 2020 sely pursued therapeutic targets of the past decade. They are considered promising targets of numer­ Accepted 15 September ous diseases including chronic pain and cancer. Modulators of these proteins, in particular TRPV1-4, 2020 TRPM8 and TRPA1, have reached clinical development, but none has been approved for clinical practice KEYWORDS yet.
    [Show full text]
  • Cryo-EM Structure of the Polycystic Kidney Disease-Like Channel PKD2L1
    ARTICLE DOI: 10.1038/s41467-018-03606-0 OPEN Cryo-EM structure of the polycystic kidney disease-like channel PKD2L1 Qiang Su1,2,3, Feizhuo Hu1,3,4, Yuxia Liu4,5,6,7, Xiaofei Ge1,2, Changlin Mei8, Shengqiang Yu8, Aiwen Shen8, Qiang Zhou1,3,4,9, Chuangye Yan1,2,3,9, Jianlin Lei 1,2,3, Yanqing Zhang1,2,3,9, Xiaodong Liu2,4,5,6,7 & Tingliang Wang1,3,4,9 PKD2L1, also termed TRPP3 from the TRPP subfamily (polycystic TRP channels), is involved 1234567890():,; in the sour sensation and other pH-dependent processes. PKD2L1 is believed to be a non- selective cation channel that can be regulated by voltage, protons, and calcium. Despite its considerable importance, the molecular mechanisms underlying PKD2L1 regulations are largely unknown. Here, we determine the PKD2L1 atomic structure at 3.38 Å resolution by cryo-electron microscopy, whereby side chains of nearly all residues are assigned. Unlike its ortholog PKD2, the pore helix (PH) and transmembrane segment 6 (S6) of PKD2L1, which are involved in upper and lower-gate opening, adopt an open conformation. Structural comparisons of PKD2L1 with a PKD2-based homologous model indicate that the pore domain dilation is coupled to conformational changes of voltage-sensing domains (VSDs) via a series of π–π interactions, suggesting a potential PKD2L1 gating mechanism. 1 Ministry of Education Key Laboratory of Protein Science, Tsinghua University, Beijing 100084, China. 2 School of Life Sciences, Tsinghua University, Beijing 100084, China. 3 Beijing Advanced Innovation Center for Structural Biology, Tsinghua University, Beijing 100084, China. 4 School of Medicine, Tsinghua University, Beijing 100084, China.
    [Show full text]